AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
SAN FRANCISCO -- Plasma levels of C-peptide appear to correlate with breast cancer risk and may show potential as a blood marker for the disease, data from the Harvard Nurses' Study suggest.
The relative risk of breast cancer for women whose C-peptide levels were in the highest quintile was 68% higher than that of women in the lowest quintile, Dr. Celia Byrne said at the annual meeting of the American Association for Cancer Research. The risk rose steadily as C-peptide levels increased. In women who had high C-peptide levels and were premenopausal at the time their blood was drawn, the relative risk of breast cancer was 221% higher, compared with that of women in the lowest quintile.
C-peptide is the fragment left when proinsulin is cleaved to create insulin, Dr. Byrne explained. Although it is not clear whether C-peptide has any physiologic activity of its own, high levels are correlated with age, high body mass index, and a sedentary lifestyle, probably because those conditions are linked to greater insulin secretion. Physical ...